The patent for brand-name Aceon has expired, and generic versions are now available. The generic tablets come in three strengths and are considered equivalent to the brand-name drug. Some of the companies that make a generic version include Aurobindo Pharma and Roxane Laboratories, Inc.
Generic Aceon: An Overview
Aceon® (perindopril erbumine) is a prescription medication that has been approved to treat high blood pressure (hypertension). It is part of a class of drugs called angiotensin-converting enzyme inhibitors, or ACE inhibitors for short. This medication helps to block the angiotensin-converting enzyme, which is normally part of a reaction in the body that causes blood vessels to narrow (constrict).
By blocking this enzyme, Aceon causes blood vessels to relax, which can lower blood pressure.
Aceon was originally developed by Solvay Pharmaceuticals. However, the patent has expired, and Aceon is now available in generic form.
Strengths of Generic AceonGeneric Aceon tablets are available in the following strengths:
- Perindopril 2 mg
- Perindopril 4 mg
- Perindopril 8 mg.
Who Makes Generic Aceon?Generic Aceon is made by a few different generic manufacturers, such as:
- Aurobindo Pharma
- Teva Specialty Pharmaceuticals
- Roxane Laboratories, Inc.
Is Generic Perindopril as Good as Aceon?
All generic medications must undergo certain tests to compare them to brand-name medications. The U.S. Food and Drug Administration (FDA) then looks at these tests to decide if the generics are equivalent to the brand-name medications and assigns each generic a rating.
An "AB" rating means the FDA has determined that a generic medication is equivalent to a brand-name medication. All of the generic perindopril versions currently available have an "AB" rating, meaning they should be equivalent to Aceon.
However, generic medications are allowed to have different inactive ingredients than the brand-name medication. This might include fillers, dyes, or other ingredients that may cause problems for people with allergies or sensitivities.